ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate

C24H25BrN4O2S — CID 133155500

IUPACethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate
SMILESCCOC(=O)CN1C(=S)NC(c2ccccn2)C1c1cc(C)n(-c2ccc(Br)cc2)c1C
InChIInChI=1S/C24H25BrN4O2S/c1-4-31-21(30)14-28-23(22(27-24(28)32)20-7-5-6-12-26-20)19-13-15(2)29(16(19)3)18-10-8-17(25)9-11-18/h5-13,22-23H,4,14H2,1-3H3,(H,27,32)
InChIKeyJKIWIZNPVREPLM-UHFFFAOYSA-N
MW513.46 g/mol
LogP4.79
Rot. Bonds6

About ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate

ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate (PubChem CID 133155500) has the molecular formula C24H25BrN4O2S and a molecular weight of 513.46 g/mol. Its IUPAC name is ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate.

Molecular Properties

Compound Nameethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate
PubChem CID133155500
Molecular FormulaC24H25BrN4O2S
Molecular Weight513.46 g/mol
Exact Mass512.09
IUPAC Nameethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate
SMILESCCOC(=O)CN1C(=S)NC(c2ccccn2)C1c1cc(C)n(-c2ccc(Br)cc2)c1C
InChIInChI=1S/C24H25BrN4O2S/c1-4-31-21(30)14-28-23(22(27-24(28)32)20-7-5-6-12-26-20)19-13-15(2)29(16(19)3)18-10-8-17(25)9-11-18/h5-13,22-23H,4,14H2,1-3H3,(H,27,32)
InChIKeyJKIWIZNPVREPLM-UHFFFAOYSA-N
XLogP4.79
TPSA59.39 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500513.46
LogP ≤ 54.79
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'pyrrole_A(118)', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate?
The IUPAC name of ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate (CID 133155500) is ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate.
What is the SMILES notation for ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate?
The canonical SMILES for ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate is CCOC(=O)CN1C(=S)NC(c2ccccn2)C1c1cc(C)n(-c2ccc(Br)cc2)c1C.
What is the InChIKey of ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate?
The InChIKey is JKIWIZNPVREPLM-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H25BrN4O2S/c1-4-31-21(30)14-28-23(22(27-24(28)32)20-7-5-6-12-26-20)19-13-15(2)29(16(19)3)18-10-8-17(25)9-11-18/h5-13,22-23H,4,14H2,1-3H3,(H,27,32).
What are the key properties of ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate?
ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate has a molecular weight of 513.46 g/mol, XLogP of 4.79, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[5-[1-(4-bromophenyl)-2,5-dimethylpyrrol-3-yl]-4-pyridin-2-yl-2-sulfanylideneimidazolidin-1-yl]acetate is sourced from PubChem (CID 133155500), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).